查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529604

智慧吸入器市场规模、份额和趋势分析：按类型、适应症、分销管道、最终用途、地区和细分市场预测，2024-2030 年

Smart Inhalers Market Size, Share & Trends Analysis Report By Type, By Indication, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

智慧吸入器市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球智慧吸入器市场规模预计将达到533亿美元，2024年至2030年复合年增长率为19.4%。

智慧吸入器市场的成长是由几个关键因素推动的，例如呼吸系统疾病盛行率的上升、意识提升的增强、数位技术与医疗设备的整合以及市场参与者对先进产品的开拓。全球慢性呼吸道疾病（尤其是气喘和慢性阻塞性肺病）的增加，因污染和免疫力减弱而加剧，刺激了对吸入器的需求。据美国肺臟协会称，到 2022 年，大约 1,170 万美国（即 4.6% 的成年人）将被诊断患有慢性阻塞性肺病，这将推动对技术先进的吸入器的需求。

智慧吸入器比传统吸入器具有优势，包括剂量提醒、健康追踪、依从性支持和资料驱动的见解。市场参与者正在积极投资创新解决方案，以满足不断变化的需求。例如，Aptar Pharma于2022年4月推出了HeroTracker Sense，将传统吸入器转变为智慧型设备，并于2020年1月与Lupin Limited合作，透过「MyAdhero」应用程式追踪药物使用情况，推出了追踪ADHERO设备。这些进步预计将推动全球对智慧吸入器的需求。

此外，政府和私营部门的措施正在提高人们对呼吸道疾病的认识。美国肺臟协会的因应慢性阻塞性肺病计划于 2022 年 11 月启动，旨在改善美国 1,250 万名慢性阻塞性肺病患者的照护。这些努力，加上先进设备的不断增加，为智慧吸入器市场的成长做出了重大贡献。

智慧吸入器市场报告亮点

  • 按类型划分，市场分为干粉吸入器（DPI）和定量吸入器（MDI）。 2023年，MDI细分市场的收益占有率最大，为64.0%，预计2024年至2030年将实现最快成长。这是因为MDI使用方便，作为可在短时间内进行喷雾的计量喷雾器越来越受欢迎。
  • 根据适应症，市场分为气喘、慢性阻塞性肺病（COPD）等。由于 COPD 在全球范围内的高盛行率以及人们对该疾病的认识不断提高，COPD 细分市场在 2023 年将占据市场主导地位，其销售份额将达到 50.7%。此外，预计其他细分市场在预测期内将以 21.8% 的复合年增长率增长最快。
  • 此市场依分销管道分为医院、零售和网路药局。 2023年，医院药局业务收益占有率最大，为44.3%。医院药局为住院患者购买智慧吸入器提供了更大的灵活性、舒适性和便利性。此外，预计线上药局领域在预测期内将以 22.1% 的复合年增长率增长最快。
  • 根据最终用途，市场分为医院、居家医疗等。医院细分市场占据主导地位，到 2023 年，市场占有率将达到 51.3%。这一增长是由医疗基础设施的快速进步和公私合营的扩展所推动的。预计 2024 年至 2030 年，居家医疗领域将以 20.3% 的复合年增长率快速成长。
  • 2023年，由于医疗基础设施的发展和先进医疗设备的采用，北美地区占收益占有率最大，为45.1%。然而，由于数位医疗设备的采用不断增加以及人们对智慧吸入器优势的认识不断增强，亚太地区预计将以 21.2% 的复合年增长率实现最快的增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章智慧吸入器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 产业分析
    • 使用者观点分析
    • 主要最终用户
  • 技术展望
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 智慧型吸入器市场分析工具
    • 波特的分析
    • PESTEL分析
  • 智慧吸入器产业关键交易及策略联盟分析
  • COVID-19 的影响

第四章智慧吸入器市场：类型估计和趋势分析

  • 定义和范围
  • 2023 年及 2030 年类型市场占有率分析
  • 细分仪表板
  • 智慧吸入器市场：按类型划分，2018-2030

第五章 智慧吸入器市场：适应症估计与趋势分析

  • 定义和范围
  • 2023 年和 2030 年指示市场占有率分析
  • 细分仪表板
  • 智慧吸入器市场：依适应症分类，2018-2030

第六章 智慧吸入器市场：通路估算与趋势分析

  • 定义和范围
  • 2023 年及 2030 年通路市场占有率分析
  • 细分仪表板
  • 智慧吸入器市场：依分销管道划分，2018-2030

第七章智慧吸入器市场：最终用途估计与趋势分析

  • 定义和范围
  • 2023 年及 2030 年最终用途市场占有率分析
  • 细分仪表板
  • 智慧吸入器市场：依最终用途分类，2018-2030 年

第 8 章 智慧吸入器市场：区域估计与趋势分析，按国家、按类型、按适应症、按分销管道、按最终用途

  • 定义和范围
  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概述
  • SWOT分析
  • 2023 年和 2030 年智慧吸入器市场占有率（按地区），十亿美元
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司市场占有率分析
  • 企业热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Presspart Verwaltungs GmbH.
    • Personal Air Quality Systems Pvt Ltd
    • COHERO Health Inc.（AptarGroup, Inc.）
    • Cognita Labs
    • adherium
    • Amiko Digital Health Limited.
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health（ResMed）
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M
    • AireHealth, Inc.
    • FindAir Sp. z oo
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Growth & Trends:

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the smart inhaler market is driven by several key factors, including the rising prevalence of respiratory diseases, increased awareness initiatives, the integration of digital technologies in medical devices, and the development of advanced products by market players. The global rise in chronic respiratory diseases, exacerbated by pollution and low immunity, particularly asthma and COPD, fuels demand for inhalers. According to the American Lung Association, approximately 11.7 million people in the U.S., or 4.6% of adults, were diagnosed with COPD in 2022, which is expected to boost demand for technologically advanced inhalers.

Smart inhalers offer benefits over traditional ones, such as dosage reminders, health tracking, adherence support, and data-driven insights. Market players are actively investing in innovative solutions to meet evolving demands. For example, Aptar Pharma introduced HeroTracker Sense in April 2022, transforming conventional inhalers into smart devices, and partnered with Lupin Limited in January 2020 to launch the ADHERO device, which tracks medication usage via the "MyAdhero" application. These advancements are anticipated to drive global demand for smart inhalers.

In addition, government and private sector initiatives are enhancing awareness about respiratory diseases. The American Lung Association's "Addressing COPD" project, launched in November 2022, aims to improve the care of 12.5 million COPD patients in the U.S. Such efforts, combined with the growing availability of advanced devices, significantly contribute to the smart inhaler market's growth.

Smart Inhalers Market Report Highlights:

  • Based on type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). The MDI segment held the largest revenue share of 64.0% in 2023 and is anticipated to witness fastest growth from 2024 to 2030. This is attributable to their increasing popularity as they are easy to use in fixed-dose short bursts sprays
  • Based on indication, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The COPD segment dominated the market with a revenue share of 50.7% in 2023, owing to the high prevalence of COPD globally and increasing awareness about this disease. Moreover, the other segment is anticipated to showcase the fastest growth of CAGR 21.8% over the forecast period
  • Based on distribution channel, the market is segmented into hospital, retail, and online pharmacies. The hospital pharmacies segment held the largest revenue share of 44.3% in 2023. Hospital pharmacies offer better flexibility, comfort, and convenience for purchasing smart inhalers for hospitalized patients. In addition, the online pharmacies segment is expected to grow at the fastest CAGR of 22.1% over the forecast period
  • Based on end use, the market is segmented into hospitals, home care settings, and others. The hospitals segment dominated the market with a market share of 51.3% in 2023. The growth is attributed to the rapid advancements in healthcare infrastructure and expanding public-private partnerships. The home care settings segment is anticipated to showcase fastest growth at a CAGR 20.3% from 2024 to 2030
  • In 2023, North America held the largest revenue share of 45.1%, due to its developed healthcare infrastructure and adoption of advanced medical devices. However, Asia Pacific is projected to experience the fastest growth at a CAGR of 21.2%, driven by increasing adoption of digital medical devices and rising awareness of smart inhaler benefits in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Inhalers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Development of technologically advanced solutions
      • 3.5.1.3. Growing adoption of digital health technologies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Higher cost than traditional inhalers
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Smart Inhalers Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape
  • 3.7. Major Deals & Strategic Alliances Analysis in the Smart Inhalers Industry
  • 3.8. Impact of COVID-19

Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Smart Inhalers Market: By Type, 2018 to 2030
    • 4.4.1. Dry Powdered Inhalers (DPIs)
      • 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Metered Dose Inhalers (MDIs)
      • 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Smart Inhalers Market: By Indication, 2018 to 2030
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. COPD
      • 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.3. Others
      • 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Smart Inhalers Market: By Distribution Channel, 2018 to 2030
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2023 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Smart Inhalers Market: By End Use, 2018 to 2030
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. Homecare Settings
      • 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Smart Inhalers Market Share, By Region, 2023 & 2030, USD Billion
  • 8.7. North America
    • 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. U.K. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.7. Russia
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.7. SIngapore
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.3. Mexico
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.4. Argentina
      • 8.10.4.1. Key Country Dynamics
      • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.2. South Africa
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.4. UAE
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Presspart Verwaltungs GmbH.
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. Personal Air Quality Systems Pvt Ltd
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. Cognita Labs
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. adherium
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Amiko Digital Health Limited.
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Teva Pharmaceuticals Industries Ltd.
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Propeller Health (ResMed)
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Novartis AG
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Pneuma Respiratory Inc.
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. 3M
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments
    • 9.6.12. AireHealth, Inc.
      • 9.6.12.1. Participant's Overview
      • 9.6.12.2. Financial Performance
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Recent Developments
    • 9.6.13. FindAir Sp. z o.o
      • 9.6.13.1. Participant's Overview
      • 9.6.13.2. Financial Performance
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 17 Europe smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Europe smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 UK smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 20 UK smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 21 UK smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 UK smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 25 Germany smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Germany smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 France smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 France smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 29 France smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 France smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 Italy smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 32 Italy smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 33 Italy smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Italy smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 Spain smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 Russia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Russia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 41 Russia smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Russia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 49 Japan smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Japan smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 China smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 China smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 53 China smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 China smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 India smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 56 India smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 57 India smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 India smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 60 Australia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 61 Australia smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Australia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 64 South Korea smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66 Singapore smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 67 Singapore smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 68 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Singapore smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73 Latin America smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Brazil smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 78 Mexico smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 79 Mexico smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 80 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Mexico smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 82 Argentina smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 83 Argentina smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 84 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 Argentina smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 86 MEA smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 87 MEA smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 88 MEA smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 89 MEA smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 90 South Africa smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 91 South Africa smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 92 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93 South Africa smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 98 UAE smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 99 UAE smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 100 UAE smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 101 UAE smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Smart Inhalers Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Smart Inhalers - Market Size and Growth Prospects (USD Million)
  • Fig. 12 Smart Inhalers Market : Industry Value Chain Analysis
  • Fig. 13 Smart Inhalers Market : Market Dynamics
  • Fig. 14 Smart Inhalers Market : PORTER's Analysis
  • Fig. 15 Smart Inhalers Market : PESTEL Analysis
  • Fig. 16 Smart Inhalers Market Share by type 2023 & 2030 (USD Million)
  • Fig. 17 Smart Inhalers Market ,by type: Market Share, 2023 & 2030
  • Fig. 18 Dry Powedered Inhalers (DPIs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Metered Dose Ihalers (MDIs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Smart Inhalers Market , by Indication: Key Takeaways
  • Fig. 21 Smart Inhalers Market , by Indication: Market Share, 2023 & 2030
  • Fig. 22 Asthma Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 COPD Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Smart Inhalers Market , by Distribution Channel: Key Takeaways
  • Fig. 26 Smart Inhalers Market , by Distribution Channel: Market Share, 2023 & 2030
  • Fig. 27 Hospital Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 Retail Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Online Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Smart Inhalers Market , by End Use: Key Takeaways
  • Fig. 31 Smart Inhalers Market , by End Use: Market Share, 2023 & 2030
  • Fig. 32 Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 33 Homecare Settings Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Smart Inhalers Market Revenue, by Region, 2023 & 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 North America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK Smart Inhalers Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 43 Germany Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 44 France Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 45 Italy Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 46 Spain Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 47 Russia Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 48 Asia Pacific Smart Inhalers Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 India Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Singapore Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 MEA Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Company Categorization
  • Fig. 63 Company Market Positioning
  • Fig. 64 Key Company Market Share Analysis, 2023
  • Fig. 65 Strategic Framework